Accuracy of contrast-enhanced breast ultrasound for pre-operative tumor size assessment in patients diagnosed with invassive ductal carcinoma of the breast

Cancer Imaging

Volumn 7, Issue 1, 2007, Pages 63-68

  van Esser, S ^a   Veldhuis, W B ^a   van Hillegersberg, R ^a   van Diest, P J ^a   Stapper, G ^a   El Ouamari, M ^a   Borel Rinkes, I H M ^a   Mali, W P Th M ^a   van den Bosch, M A A J ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Accuracy; Breast cancer; Contrast enhanced ultrasound; SonoVue; Tumor size

Indexed keywords

SONOVUE; CONTRAST AGENT BR1; DIAGNOSTIC AGENT; PHOSPHOLIPID; SULFUR HEXAFLUORIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CARCINOMA; BREAST SURGERY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOMAMMOGRAPHY; FEMALE; GRAY SCALE ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MICROBUBBLE; NEEDLE BIOPSY; PATIENT SAFETY; PREOPERATIVE EVALUATION; SCORING SYSTEM; SINGLE DRUG DOSE; TRANSDUCER; TUMOR VOLUME; BREAST TUMOR; ECHOGRAPHY; EVALUATION; METHODOLOGY; MIDDLE AGED; PAGET NIPPLE DISEASE; PREOPERATIVE CARE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MIDDLE AGED; PHOSPHOLIPIDS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE;

EID: 34447109797     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2007.0012     Document Type: Article

References (20)

1. Del Cura JL, Elizagaray E, Zabala R, Legorburu A, Grande D. The use of unenhanced Doppler sonography in the evaluation of solid breast lesions. AJR Am J Roentgenol 2005; 184: 1788-94.
2. American College of Radiology. edn. In: Breast imaging reporting and data system: ultrasound; 4thReston, VA: American College of Radiology, 2003.
3. Hall-Craggs MA, Vaidya JS. Minimally invasive therapy for the treatment of breast tumours. Eur J Radiol 2002; 42: 52-7.
4. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005; 235: 728-39.
5. Fredriksson I, Liljegren G, Palm-Sjovall M, et al. Risk factors for local recurrence after breast conserving surgery. Br J Surg 2003; 90:1093-101
6. Asgeirsson KS, McCulley SJ, Pindet SE, Macmillan RD. Size of invasive breast cancer and risk of local recurrence after breast-conservation therapy. Eur J Cancer 2003; 39: 2462-9.
7. Fornage BD, Toubas O, Morel M. Clinical, mammographic, and sonographic determination of preoperative breast cancer size. Cancer 1987; 60: 765-71.
8. Tresserra F, Feu J, Grases PJ, et al. Assessment of breast cancer size: sonographic and pathologic correlation. J Clin Ultrasound 1999; 27: 485-91.
9. Allen SA, Cunliffe WJ, Gray J, et al. Pre-operative estimation of primary breast cancer size: a comparison of clinical assessment, mammography and ultrasound. Breast 2001; 10: 299-305.
10. Finlayson CA, MacDermott TA. Ultrasound can estimate the pathologic size of infiltrating ductal carcinoma. Arch Surg 2000; 135: 158-9.
11. Shoma A, Moutamed A, Ameen M, Abdelwahab A. Ultrasound for accurate measurement of invasive breast cancer tumor size. Breast J 2006; 12: 252-6.
12. Golshan M, Fung BB, Wiley E, Wolfman J, Rademaker A, Morrow M. Prediction of breast cancer size by ultrasound, mammography and core biopsy. Breast 2004; 13: 265-71.
13. Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US and MR imaging in preoperative assessment of breast cancer. Radiology 2004; 233: 830-49.
14. Heusinger K, Lohberg C, Lux MP, et al. Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself. Breast Cancer Res Treat 2005; 94: 17-23.
15. Kwee RM, Van den Bosch MAAJ, ElOuamari M, et al. Contrast-enhanced breast ultrasonography reveals an unusual breast tumor in a male patient with gynecomastia. J Ultrasound Med 2006; 25: 1347-51.
16. Kook SH, Kwag HJ. Value of contrast-enhanced power Doppler sonography using a microbubble echo-enhancing agent in evaluation of small breast lesions. J Clin Ultrasound 2003; 31: 227-38.
17. Greis C. Technology overview: SonoVue. Eur Radiol 2004; 14(Suppl 8): 11-15.
18. Madjar H. Contrast ultrasound in breast tumor characterization: present situation and future tracks. Eur Radiol 2001; 11(suppl 3): E41-6.
19. Bokor D, Chambers JB, Rees PJ, Mant TG, Luzzani F, Spinazzi A. Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Invest Radiol 2001; 36: 104-9.
20. Caruso G, Ienzi P, Cirino, A, et al. Breast lesion characterization with contrast-enhanced US. Work in progress. Radiol Med (Torino) 2002; 104: 443-50.